key: cord-0255531-f6vpdk9s
authors: Padmanabhan, Pranesh; Dixit, Narendra M.
title: Evidence of increased Cathepsin B/L and decreased TMPRSS2 usage for cell entry by the SARS-CoV-2 Omicron variant
date: 2022-01-18
journal: bioRxiv
DOI: 10.1101/2022.01.13.476267
sha: fe4151049153018f3f8b707135b9b32968bafea8
doc_id: 255531
cord_uid: f6vpdk9s

The SARS-CoV-2 Omicron variant appears to exhibit altered cell tropism and entry properties compared to other variants. Here, analysing recent data, we found a strong positive correlation between the entry efficiency of the Omicron variant and the relative usage of the host protease Cathepsin B/L by the original SARS-CoV-2 strain for cell entry. We developed a mathematical model to quantify entry efficiency in in vitro assays and found that the Omicron variant displayed >4-fold improved efficiency in using Cathepsin B/L for entry in 293T-ACE2 cells compared to the original strain. The preferential usage of Cathepsin B/L over TMPRSS2 for entry may explain the altered cell tropism of the Omicron variant and have implications for our understanding of its infectivity and transmissibility as well as for interventions.

The new SARS-CoV-2 variant Omicron (B.1.1.529), declared a variant of concern on 30 25 th November 2021, is fast becoming the dominant strain in several countries. It harbours as 31 many as 37 mutations in the spike protein compared to the original SARS-CoV-2 strain [1] and 32 is able to evade neutralising antibodies generated by previously infected or vaccinated 33 individuals [1] [2] [3] , possibly leading to its increased transmissibility and rapid global spread. 34

Emerging data indicates that the high number of mutations in the Omicron variant affects its 35 viral entry properties and cell tropism [2-5], which in turn may influence its ability to establish 36 infection post-exposure and the severity of the subsequent symptoms. In this letter, we analyse 37 this new data and find that the Omicron variant has substantially altered preferences for cell 38 entry pathways compared to the earlier variants. Further, using a mathematical model, we 39 quantify the extent of the differential usage of the entry pathways by the Omicron variant. We thank Rajat Desikan for help with Figure 1A . In B and C, experimental data was extracted using Engauge Digitizer 12.1. In C, Data was fit 174 using the tool NLINFIT in MATLAB R2017b. 175

Broadly 141 neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift

143 mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-144 2 Omicron variant

The Omicron variant is highly resistant against antibody-mediated 146 neutralization -implications for control of the COVID-19 pandemic

SARS-CoV-2 Omicron variant 148 shows less efficient replication and fusion activity when compared with delta variant in 149 TMPRSS2-expressed cells

SARS-CoV-2 Omicron spike 151 mediated immune escape, infectivity and cell-cell fusion

CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven 154 protease inhibitor

SARS-CoV-2 cell tropism and 156 multiorgan infection

TMPRSS2 expression 158 dictates the entry route used by SARS-CoV-2 to infect host cells

Targeting TMPRSS2 and Cathepsin B/L together 160 may be synergistic against SARS-CoV-2 infection

Hydroxychloroquine-mediated 162 inhibition of SARS-CoV-2 entry is attenuated by TMPRSS2

The authors declare that no conflicts of interests exist. 137 138